Hubungan Antara Kadar Serum Asam Urat Dan Kejadian Klinis Kardiovaskular Mayor Selama Perawatan Di Rumah Sakit Pada Pasien Penderita Sindroma Koroner Akut Di Rumah Sakit Umum Pusat Haji Adam Malik Medan

  DAFTAR PUSTAKA

  Achar S, Kundu S, Norcross W. (2005). Diagnosis of acute coronary syndrome.Am Fam Physician 72:119-26. ACSM Coronary Artery Disease Risk Factor Thresholds. Diunduh dari

   Akanda MAK, Choudhury KN, Ali MZ et all. Serum uric acid and its association with coronaryartery disease. Cardiovasc.Journal. 2012; 5(1):12-17.

  Alderman M, Aiyer KJV. Uric Acid: Role in Cardiovascular Disease and Effects of Losartan. Curr Med Res Opin. 2004;20(3) Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats AJ.

  Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart.1997;78(1):39-43. Antman E, Anbe D, Armstrong P, et al. (2004). ACC/AHA guidelines for themanagement of patients with ST elevation myocardial infartion. A report of the American College of cardiology/ American Heart Assosiation task force inpractice guidelines). Am Coll Cardiol J 44 (suppl I) :1-212

  Antman EM. ST-segment elevation myocardial infarction: Pathology, Pathophysiology, and Clinical features. In Bonow RO, Mann DL, Zipes DP, Libby P,Braunwald E, editors. Heart disease : A textbook of cardiovascular medicine. Ninth edition. Philadelphia:Elsevier, 2Ol2;p.

  1087-1099.

  Bender J, Russel K, Rosenfeld E, Chaundry S, (2011). Oxford American Handbook of Cardiology . New York : Oxford. p. 256-260

  Berne, M (1980), “ The role of adenosine in the regulation of coronary blood flow”, Circulation Research, Vol.47,807-813. Berry CE and JM Hare. 2004. Xanthine Oxidoreductase and

  Cardiovascular Disease: Molecular Mechanism and Pathophysiological Implications. Am JPhysiol, pp: 589-606. Blankenship JC, Moussa ID, Chambers CC, et all. Staging of Multivessel

  Percutaneous Coronary Interventions: an Expert Concencus Statement from the Society for Cardiac Angiography and Interventions.

  Catheterization and Cardiovascular Interventions 00:000–000 (2011). Budaj A, David B, Gabriel S, et al. (2003). Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J.;146 : 999-1006.

  Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension.

  Hypertension 2000;35:746-51 Brand FN, McGee DL, Kannel WB, Stokes JD, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J

  Epidemiol. 1985;121:11–18. Car S, Trkulja V. Higher serum uric acid on admission is associated with higher short term Mortality and poorer longterm survival after myocardial infarction: retrospective prognostic study. Croat Med J 2009;50:599- 566.

  Castelli, P; Condemi, AM; Brambillasca, C; Fundaro,P; Botta, M; Lemma, M; Vanelli, P; Santoli,C; Gatti, S and Riva, E (1995), “ Improvement of cardiac function by allupurinol in patients undergoing cardiac surgery”, Journal of Cardiovascular Pharmacology, Vol. 25, 119-125.

  ChristopherB. Granger, Robert J. Goldberg, Omar Dabbous, Karen S. Pieper, Kim

  A. Eagle,Christopher P. Cannon, et all. Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events. Arch Intern Med. 2003;163:2345-2353. Costa, F; Sulur, P; Angel, M; Cavalcate, J; Haile, V; Christman, B and Biaggioni,

  I (1999), “ Intravascular source of adenosine during forearm ischemia in humans implivations for reactive hyperemia”, Hypertension, Vol. 33, 1453-1457. Culleton BF, Larson MG, Kannel WB, Levy D. Serum Uric Acid and Risk for

  Cardiovascular Disease and Death: The Framingham Heart Study. Ann Intern Med. 1999;131:7-13. Departemen Kesehatan RI. (2008). Riset Kesehatan Dasar 2007. Deveci OS, Kabakci G, Okutucu S, Tulumen E, Aksoy H, Kaya EB, et al. The association between serum uric acid level and coronary artery disease.

  Int J Clin Pract.2010;64(7):900-907. doi: 10.1111/j.1742- 1241.2009.02263.x. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerosis heart disease. N Engl J Med.1997;337(6):408-416. Dietrich M, Block G, Norkus EP, Hudes M, Traber MG, Cross CE, et al. Smoking and exposure to environmental tobaco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nuts 2003;77:160-166.

  Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002;105:2619-24

  Duran M, Kalay N, Akpek M, Orscelik O, et all. High Levels of serum uric acid predict severityof coronary artery disease in patient with acute coronary syndrome. Angiology. August2012 vol. 63 no. 6 448-452

  Emmerson, BT (1996), “ The management of Gout”, New England Journal of Medicine, Vol. 334,445-451. Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Müller M,

  Fuchs M et all.Allopurinol Attenuates Left Ventricular Remodeling and Dysfunction AfterExperimental Myocardial Infarction: A New Action for an Old Drug? Circulation. 2004;110;2175-2179.

  Feig DI, Duk HK, JohnsonRJ,Uric Acid and Cardiovascular Risk. NEJM 2008;359:1811-21. Francis H. McCrudden, 2000, Uric Acid. Penterjemah Suseno Akbar, Salemba

  Medika: Yogyakarta Fredholm,BB andSollevi, A (1986), “ Cardiovascular effects of adenosine “, Metabolism, Vol. 30,616-634.

  Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med.

  1951;34:1421-1431. Gur M, Yilmaz R, Demirbag R, Aksoy N. Relation of serum uric acid levels with the presenceand severity of angiographic coronary artery disease.

  Angiology. 2008;59(2):166-171. doi:10.1177/0003319706292010. Goraca A, Skibska B. Plasma antioxidant status in healthy smoking and non smoking men. Bratistl L Listy 2005;106:301-306.

  Hamm W, Heeschen C, Falk E, Fox K. (2004). Acute coronary syndrome : Pathophysiology, Diagnosis and risk stratification.Elsevier, p.333-367.

  Hansson GK. (2005). Inflammation, Atherosclerosis, and Coronary Artery Disease.N Engl J Med; 352 (16): 1685-95. Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure : insights regarding therole of xanthine oxidaseand uric acid in disease pathophysiology. Circulation 2003;107:1951-1953. Hediger MA, Johnson RJ, Miyazaki H,Endou H. 2005. Molecular Physiology of Urate Transport. Am J Physiol, pp: 125-33. Hicks KA, Hung HMJ, Mahaffey KW, Mehran R, Nissen SE, Stockbridge NL,

  Targum SL,Temple R. Standardized defininitions for end point events in cardiovascular trials. Circulation 2010; 20:1-37. Hoieggen A, Fossum E, Reims H, Kjeldsen SE. Serumuric acidand hemorheology in Borderline hypertensives and in subjects with established hypertension and left ventricular hypertrophy. Blood Press 2003;12:104-10

  Homayounfar, S; Ansari, M and Kashani, KM (2007), “Evaluation of independent prognostic importance of hyperuricemia in hospital death after acute myocardial infarction”, Saudi Medical Journal, Vol. 28, 759-761. Ian J. et al. (2012). Coronary Angiographic Scoring Systems An Evaluation of

  Their Equivalence and Validity.Am Heart J. 2012;164(4):547-552.e1 Ismail D. Patofisiologi Sindroma Koroner Akut. Dalam : Bawazier LA, Alwi

  I,Syam AF dkk. Editors. Prosiding Simposium Pendekatan Holistik Penyakit.Kardiovaskuler (2001). Jakarta : Pusat Informasi dan Penerbitan Bagian IlmuPenyakit Dalam FK UI ; 2001.hal.22

  Johnson RJ, Rodriquez-Iturbe B, Kang DH, et al. Aunifying pathwayfor essential hypertension. AM J Cardiol 2002;89:12-7 Karlsberg RP, Tcheng JE, Boris JR, Buxton AE, Dove JT, Fonarow GC, dkk.

  ACCF/AHA 2011 Key data elements and definitions of a base cardiovascular vocabulary for electronic health records. J Am Coll

  Cardiol. 2011;58(2):202-222.

  Kaya MG, Uyarel H, Akpek M, Kalay N, et all, Prognostic Value of Uric Acid in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention. Am J Cardiol 2012;109:486 – 491.

  Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

  Arthritis CareRes.2010;62(2):170-180. doi:10.1002/acr.20065. Kojima S, Sakamato T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M et all.

  Prognostic Usefulness of Serum Uric Acid After Myocardial Infarction (The Japanese Acute Coronary Syndrome Study). Am J Cardiol. 2005;96:489-495. Krishnan E, Svendson K, Neaton JD, Grandits G, Kuller LH. Long-term

  Cardiovascular Mortality Among Middle-aged Men with Gout. Arch Intern Med. 2008;168(10):1104-10. Kroll, K; Bukowski, TR; Schwartz, LM; Knoepfler, D and Bassingthwaighte, JB

  (1992), Capillary endothelial transport of uric acid in guinea pig heart”, American Journal of physiology, Vol. 262,420-431. Kumar A, Cannon P. (2009). Acute Coronary Syndromes: Diagnosis and

  Management, Part I Mayo Clin Proc : 84(10):917-93 Kojima S, Sakamoto T, Ishihara M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (Japanese Acute coronary Syndrome

  Study). Am J Cardiol 2005;96:489-95. Li Chen, Xian-lin Li, Qiao W, Ying Z, Qin Y-L, Wang Y, Zeng Y-J, Ke Y-n.

  Serum uric acid in patients with acute ST-elevation myocardial infarction. Word J Emerg Med, Vol 3, No 1, 2012. Lippi G, Montagnana M, Luca Salvagno G, Targher G, Cesare Guidi G.

  Epidemiological association between uricacid concentrationin plasma, lipoprotein (a) and the traditional lipid propile Clin Cardiol 2010;33:76-

  80. Levine G, Eric R, James C et al. (2011). ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation.124:1-82. London M, Hums M., Distribution patterns of uric acid in coronary artery disease.

  Clinical Chemistry February 1967 vol. 13 no. 2 132-141 Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997;18:858-65

  Mandell, Brian F, 2008, Cleveland Clinic Journal of Medicine: Clinical

  manifestations of hyperuricemia and gout. Department of Rheumatic

  and Immunologic Diseases, Center for Vasculitis Care and Research, Cleveland Clinic: Cleveland, OH McCaig LF, Burt CW. (2001). National Hospital Ambulatory Medical Care Survey: 1999 emergency department summary. Adv.Data 320, 1–34. McKee PA, Catell WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med.

  1971:285. Milena Soriano Marcolino, Cihan Simsek, Sanneke P.M. de Boer, Ron 1.van

  Domburg, Robert-Jan van Geuns, Peter de Jaegere. Short-and Long- term Major Cardiac Events in patients undergoingpercutaneous Coronary Intervention with Stenting for Acute Myocardial Infarction complicated by cardiogenic shock. Cardiology 2012; 121:47-55

  Mustard JF, Murphy EA, Ogryzlo MA, Smythe HA.Blood coagulation and platelet economyin subjects with primary gout. Can Med Assoc J 1963;89:1207-11. Murray Robert K, Granner Daryl K, Rodwell Victir W, 2006, Harper's: Illustrated Biochemistry.

  27 Edition. McGraw Hill, Lange : Boston, Burrridge, Il dubuque, La madison, WL, New York, San Francisco, St. Louis, Bangkok, Bogota, Caracas, Kuala Lumpur, Lisbon, London, Madrid,Mexico City, Milan, Montreal, New Delhi, Santiago, Seoul, Singapore,Sydney, Taipei, Toronto.

  MY Nadkar,VI Jain. Serum Uric Acid in Acute Myocardial Infarction. JAPI. Vol 56. October 2008. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholestrol in adult (Adult treatment panel III). Circulation. 2002;106:3143. Newland H. Hyperuricemia in coronary,cerebral and peripheral arterial disease: an explanation. Med Hypotheses 1975;1:152-5. Packard R.R.S, Libby P. (2008)Clinical Chemistry

  54: 24-38. Perhimpunan Dokter Spesialis Kardiovaskuler Indonesia. (2012). Pedoman

  Tatalaksana Penyakit Kardiovaskuler di Indonesia. Edisi ke-3;2012 :3- 54. Perk J, Backer GD, Gohlke H, Reiner Z, Verschuren WMM dkk. European

  Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). European Heart Journal 2012; 33: 1635-1701. Putra, Tjokorda Raka. 2006. Hiperurisemia. In: Sudoyo dkk (ed).

  Buku Ajar Ilmu Peyakit Dalam Jilid II Edisi IV . Jakarta: FKUI, pp: 1213-17.

  Raymond J.G, Jonathan A, Kanu C et al. (2002). Guideline Update for the Management of PatientsWith Chronic Stable Angina. ACC/AHA 2002 Available from

  

  Rauch U, Osende JI, Fuster V, et al. (2001). Thrombus Formation on Atherosclerotic Plaques:Pathogenesis and Clinical Consequences. Ann Intern Med 134 : 224-38.

  Safi AJ, Mahmood r,Khan MA,Haq A.Association of serum uric acid with type II diabetes mellitus J Postgrad Med Inst 2004;18:59-63. Rathmann W, Haastert B, Icks A, Giani G, Roseman JM. Tenyear change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study. Eur J Epidemiol 2007;22:439-455. Siniša Car, Vladimir Trkulja, Higher Serum Uric Acid on Admission Is

  Associated with Higher Short - term Mortality and Poorer Long - term Survival After Myocardial Infarction: Retrospectiv Prognostic Study,Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia, doi: 10.3325/cmj.2009.50.559

  Sivakumar K, Thamarai R and Jey Pragatha R, 2014. Uric acid: a marker of increased various diseases and risks, Pharmacophore, Vol 5(1),35-43. Steele, TH (1999), :Hyperuricemic nephropathies”, Nephrology, Vol.81,45-49. Ter Arkh .Clinical implicationof endothelial dysfunction in patients with essential arterial Hypertension and urate dysbolism with renal damage.

  2011;83(10):36-40. [Article in Russian] Therax P, Foster V. (1998). Acute Coronary Syndrome: Unstable Angina and non QWave Myocard Infarction. Circulation 97: 1195-1206.

  Thygesen K. Alpert JS. Jaffe A. Simoons M, Chaitman B, White H, (2012). Third Universal Definition of Myocardial Infarction. Jam Coll Cardiol.

  2012;60(16):1581-1598. Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves Endothelium-dependent vasodilatation in patients with insulin dependent diabetes mellitus. J Am Coll Cardiol 1998;31:552-557. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, InoueM. Smoking a single cigarette rapidly reduces combined concentration of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002; 105: 1155-1157.

  Tuomilheto J, Zimmer P, Evawolf. Plasma Uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial popolution of FIJI Am J Epidemiol 1988;127:32136.

  Van de Werf F, Bax J, Betriu A, Blomdtorm-Lundgvista C, Crea F, Falk V dkk.

  Management of acute myocardial infarction in patients presenting with persisten ST segmen elevation, the task force on the management of ST segment elevation acute myocardial infarction of

European Society of Cardiology. Eur Heart J. 2008;29:2909-2945.

  World Health Organization. Deaths from Coronary Heart Disease. (2013).

  Available from Wright RS, Cynthia DA, Jeffrey LA et al. (2011). ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable

  Angina/Non_ST-Elevation Myocardial Infarction (Updating the 2007 Guideline).J. Am. Coll. Cardiol.57;1920-1959. Waring, WS; Webb, DJ and Maxwell, SRJ (2000), “ Uric acid as a risk factor for cardiovascular disease”, Qutar Journal of Medicine, Vol. 93, 707-713. Wawan Setyawan. Validasi skor TIMI dalam memprediksi mortalitas pasien sindrom coroner akut di Indonesia. Jakarta: Universitas Indonesia,

  2011. Tesis. Weller Seward E. Miller, 2002, Textbook of Clinical Pathology. Eight edition/Asian edition. Igaku Shoin, Ltd: Tokyo Xiong Z, Zhu C, Qian X, Zhu J, Wu Z, Chen L. Predictors of clinical SYNTAX score in coronary artery disease: serum uric acid, smoking, and

  Framingham risk stratification. JInvasive Cardiol. 2011;23(12):501- 504. Lampiran 1

  

LEMBAR PENJELASAN KEPADA CALON SUBYEK PENELITIAN

Hubungan antara kadar serum asam urat dan kejadian klinis kardiovaskular mayor (KKvM) selama perawatan di rumah sakit pada

penderita Sindroma Koroner Akut periode November sampai dengan 15

Desember 2014 di RSUP H. Adam Malik Medan.

  1. Bapak/Ibu/Saudara/Saudari yang terhormat Saya yang bertandatangan di bawah ini Nama : Hadi Zulkarnain Alamat : Jl.Gaperta VIII No. H-58, Komplek Kodam I/BB,

  Helvetia Medan HP : 081358034514 Adalah peserta program studi dokter spesialis ilmu penyakit jantung dan pembuluh darah Fakultas Kedokteran Universitas Sumatera Utara yang akan melaksanakan penelitian dengan judul hubungan kadar asam urat dan kejadian klinis kardiovaskular mayor (KKvM) selama perawatan di rumah sakit pada penderita Sindroma Koroner Akut periode November sampai dengan 15 Desember 2014 di RSUP H. Adam Malik Medan.

  2. Bapak/Ibu, pertama saya menjelaskan apa yang disebut sebagai Sindroma koroner akut (SKA) merupakan suatu istilah atau terminologi yang digunakan untuk menggambarkan spectrum penyakit arteri koroner yang bersifat trombotik. Kelainan dasarnya adalah ateros klerosis yang akan menyebabkan terjadinya plaque aterom. Pecahnya plaque atero mini akan menimbulkan trombus yang nantinya dapat menyebabkan iskemia hingga infark miokard. Spektrum klinis dari SKA terdiri dari angina pectoris tidak stabil/APTS (unstable angina/UA), infark miokard gelombang non-Q atau infark miokard